Skip to main content

Zura Bio Ltd

ZURA
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001855644

No open-market purchases or sales by Zura Bio Ltd insiders were filed in the last 90 days; 95 institutions reported holding it in 13F filings for Q2 2026, worth $428.9M in total; no superinvestor holds it.

Q4 2022 vs. Q3 2022

How the institutions holding Zura Bio Ltd changed between Q3 2022 and Q4 2022.

All holders in Q4 2022All holders in Q3 2022

13F holders of ZURA: Q3 2022 compared with Q4 2022
MeasureQ3 2022Q4 2022Change
Holders3335+2
Shares8.43M8.57M+139.9K (+1.7%)
Value$84.2M$87.4M+$3.23M (+3.8%)

New holders (5)

Institutions that held Zura Bio Ltd at the end of Q4 2022 but not at the end of Q3 2022.

Institutions new to ZURA in Q4 2022
InstitutionSharesValue% of portfolio
Cowen Investment Management LLC100,000$1.02M0.21%
Atlas Merchant Capital LLC100,000$1.02M0.17%
Clear Street LLC85,266$871.0K0.03%
Castle Creek Arbitrage, LLC49,998$510.5K0.04%
Landscape Capital Management, L.L.C.10,797$110.2K0.02%

Sold out (3)

Institutions that held Zura Bio Ltd at the end of Q3 2022 and filed for Q4 2022 without it.

Institutions that sold out of ZURA in Q4 2022
InstitutionShares, Q3 2022Value, Q3 2022
UBS Oconnor LLC238,623$2.40M
BNP Paribas Arbitrage, SA105,981$1.07M
Lombard Odier Asset Management (USA) Corp150,000$1.01M